Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
about
Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursementSecular trends in colon and rectal cancer relative survival.The accuracy and completeness for receipt of colorectal cancer care using Veterans Health Administration administrative data.Disparities in preventive procedures: comparisons of self-report and Medicare claims data.Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidityPredictors of preventive service use among Medicare beneficiaries.Extracting timing and status descriptors for colonoscopy testing from electronic medical records.Comparing patient and endoscopist perceptions of the colonoscopy indicationSocioeconomic status and chemotherapy use for melanoma in older people.Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancerIntegrating age and comorbidity to assess screening mammography utilizationMedical center characteristics associated with PSA screening in elderly veterans with limited life expectancy.Declining mammography screening in a state Medicaid Fee-for-Service program: 1999-2008.Influence of primary care on breast cancer outcomes among Medicare beneficiariesDifferent screening definitions have little impact on polypectomy rate estimates.The impact of PSA testing frequency on prostate cancer incidence and treatment in older men.Changes in Receipt of Cancer Screening in Medicare Beneficiaries Following the Affordable Care Act.Impact of age and comorbidity on colorectal cancer screening among older veterans.Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care.Natural language processing improves identification of colorectal cancer testing in the electronic medical record.Socioeconomic Differences in Use of Low-Value Cancer Screenings and Distributional Effects in Medicare.Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation.Racial and ethnic disparities in substance use disorders and outcomes in elderly prostate cancer patients.BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.Racial disparities in the utilization of preventive health services among older women with early-stage endometrial cancer enrolled in Medicare.Lessons from Medicare coverage of colonoscopy and prostate-specific antigen test.Improving Performance on Preventive Health Quality Measures Using Clinical Decision Support to Capture Care Done Elsewhere and Patient Exceptions.
P2860
Q24805112-F9FB8992-EB49-402A-85D8-052734475BCFQ30558513-F2E9EDF7-B80E-4ECE-977E-B1B040352D2BQ31044526-B45B862C-7D46-4885-873E-3CA7660B0957Q31063147-B9B32B6A-83AD-4F0B-8B85-CA1F7DA8D120Q33302869-F9201DA1-4D62-47F8-BEE9-2B227811A449Q34328473-E5794140-540C-4B5E-A782-9E1B35DF80D6Q34371688-60B7695F-95E1-44DC-9A65-32960EA9A7E6Q34417020-9A42BC8E-BBCE-448B-9980-2C122B74DDDCQ35050922-EB931C78-22E1-40ED-B98C-698C129CBD57Q35669141-0CFD1778-A754-48C2-BBEA-D17D8AC88BA8Q35787788-22BD4464-E219-4990-B9F2-97019FEAB258Q35980688-CA5077FF-FE8E-4AFA-8864-66287FA89561Q36138373-790D0531-057B-421D-B806-392E44C9C239Q36222876-7ED89108-26B5-4CF3-96AC-F52C972452D3Q36391786-3FF07C03-C812-413E-99F2-E25A5574173AQ36831317-C6273DF8-D1BC-4276-93F3-EE4E8D77ECB2Q36849151-30AA5CDD-F78A-4A84-8AAA-B82ED058189FQ37160408-AA1A66FE-CD2F-42AE-89B1-62CBE89A8419Q37189241-AC3A92C0-A851-446D-BC5E-6E4B81AA93C8Q37851774-20450CB4-9561-447B-8321-8CA19638B6EEQ38405673-B105AAC6-95DB-4AE5-A815-4CBE330F836CQ39062999-AA8C0373-57C7-4636-84AA-64112393D282Q39820915-0C602243-8F62-49AD-AB42-E9365609281BQ40053882-F2B43667-2D7B-42A5-BF08-18CA6C81CC20Q40094845-E91445BF-4E97-4023-B2BC-51EFE9C11D2EQ41635096-B41AD674-B7EA-45E7-A3A7-2461ED23A879Q47789535-326B3CE8-568D-41DF-B6EA-1B26398C849B
P2860
Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
@ast
Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
@en
type
label
Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
@ast
Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
@en
prefLabel
Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
@ast
Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
@en
P2093
P1433
P1476
Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
@en
P2093
Beth A Virnig
Carrie N Klabunde
Gregory S Cooper
Jean L Freeman
Joan L Warren
Nicola Schussler
P304
P356
10.1097/00005650-200208001-00005
P433
P577
2002-08-01T00:00:00Z